NCT05620186 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Soenens G, Lawaetz J, Bamelis AS, Nayahangan LJ, Konge L, Eiberg J, Van Herzeele I
International Implementation of a PROficiency based StePwise Endovascular Curricular Training (PROSPECT) in Daily Practice. Eur J Vasc Endovasc Surg. 2021 Dec;62(6):992-998. doi: 10.1016/j.ejvs.2021.09.029. Epub 2021 Nov 12.
Soenens G, Lawaetz J, Doyen B, Fourneau I, Moreels N, Konge L, Eiberg J, Van Herzeele I
Massed Training is Logistically Superior to Distributed Training in Acquiring Basic Endovascular Skills. Eur J Vasc Endovasc Surg. 2023 Nov;66(5):730-737. doi: 10.101

Registry Endovascular Training Curriculum PROSPECT for Surgical Trainees (PROficiency-based StePwise Endovascular Curricular Training Program)

Clinical trial NCT05620186 - References